The Food and Drug Administration approved Bristol Myers Squibb’s highly anticipated schizophrenia drug, the first novel type of treatment for the debilitating, chronic mental disorder in more than seven decades. #WhatDoYouThinkt.co/4rxYZQk8bmt.co/qT2zT9GIdU